Home / Clinical trials / Epitalon
Are there clinical trials for Epitalon?
Epitalon has only 1 registered clinical trial, reaching Early Phase 1, with 0 completed. That is early-stage evidence: it is not established clinical evidence of effectiveness in humans.
Trial breakdown
By phase
| Early Phase 1 | 1 |
By status
| Enrolling by invitation | 1 |
Active trials
- Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging ClocksEarly Phase 1 · Enrolling by invitation · 48 participants · Frontiers in Bioscience Research Institute and Aging · started 2026-10-21NCT07888595
Most recent registered trials
- Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging ClocksEarly Phase 1 · Enrolling by invitation · 48 participants · Frontiers in Bioscience Research Institute and Aging · started 2026-10-21NCT07888595
What Epitalon is being studied for
Most studied conditions
Who is running the studies
Counted from ClinicalTrials.gov registrations, checked 2026-11-09.
Peptides with a similar weight of evidence
Ordered by how far the registered research has progressed.
- Melanotan II1 registered study
- TB-5001 registered study
- AOD-9604no registered trials
- DSIPno registered trials
- GHRP-2no registered trials
Frequently asked questions
Are there clinical trials for Epitalon?
Epitalon has only 1 registered clinical trial, reaching Early Phase 1, with 0 completed. That is early-stage evidence: it is not established clinical evidence of effectiveness in humans.
Does a registered trial mean the peptide works?
No. Registration means a study was formally listed before or during the research. It says nothing about the result. A completed trial can find no benefit, and many registered studies are never published.
What is the difference between a registered trial and published evidence?
Registration records that a study exists. Publication reports what it found. This page counts registrations, which is the more complete picture of research activity, but it is not a measure of proven effectiveness.
Why do phases matter?
Phase 1 tests safety in a small group. Phase 2 looks for early signs of effect. Phase 3 tests effectiveness against a comparator in a large group, and is what regulators normally require. Phase 4 studies happen after approval. A compound with only Phase 1 trials has not been shown to work.
Source: ClinicalTrials.gov API v2, U.S. National Library of Medicine. Studies where Epitalon is registered as an intervention. Last updated 2026-11-09.
Related data
- Which peptides are FDA-approved →Approval status for every peptide, from Drugs@FDA
- Which peptides have clinical evidence →Registered clinical trial counts from ClinicalTrials.gov
- Peptide legality by US state →A sourced verdict for all 50 states
